Abstract
Background
Metabolic surgery causes the remission of type 2 diabetes mellitus (T2DM), hypertension, and hyperlipidemia to varying degrees, depending on the patient characteristics and the surgical procedure. The aim of this study was to find predictors for the remission of T2DM and hypertension after biliopancreatic diversion with duodenal switch (BPDDS).
Methods
Eighty patients with T2DM were followed up for 2 years or more after BPDDS, and changes in body weight and metabolic status were noted. Remission was defined as fasting glucose <7 mmol/l with HbA1C <6.5 %, blood pressure <140/90 mmHg, and low-density lipoprotein (LDL) <2.6 mmol without the use of medication.
Results
Preoperatively, the mean age was 44 years, body mass index (BMI) was 48 kg/m2, and duration of diabetes was 5 years. Of the 80 patients, 38 patients were using insulin, 48 patients were using antihypertensives, and 38 patients were using a lipid-lowering drug. Five percent of the patients had recommended levels for HbA1C, blood pressure, and LDL prior to the operation. The remission rate at 2 years was 94 % for T2DM, 54 % for hypertension, and 86 % for LDL hyperlipidemia. Preoperative predictors for nonremission of T2DM were a higher BMI, insulin usage, and low insulin C-peptide, and for hypertension, older age and more severe hypertension. Postoperative weight loss was important for both.
Conclusions
Surgical intervention with BPDDS is an effective treatment of T2DM, hypertension, and hyperlipidemia. The duration of T2DM and age of the patient are the most important preoperative predictors for the remission of T2DM and hypertension, respectively.
Similar content being viewed by others
References
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.
Hu G, et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004;164(10):1066–76.
Solli O, Jenssen T, Kristiansen IS. Diabetes: cost of illness in Norway. BMC Endocr Disord. 2010;10:15.
American Diabetes Association. Standards of medical care in diabetes—2011. Diabetes Care. 2011;34(Suppl 1):S11–61.
Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291(3):335–42.
Branca F, Nikogosian H, Lobstein T, editors. The challenge of obesity in the WHO European Region and the strategies for response. WHO regional office, Copenhagen: WHO; 2007. 324 pp.
Buchwald H, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248.e5–56.e5.
Dixon JB, et al. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011;28(6):628–42.
Chikunguwo SM, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010;6(3):254–9.
Pories WJ, et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr. 1992;55(2 Suppl):582S–5S.
Schauer PR, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–84. discussion 84–5.
Crea N, et al. Long-term results of biliopancreatic diversion with or without gastric preservation for morbid obesity. Obes Surg. 2011;21(2):139–45.
Gracia-Solanas JA, et al. Metabolic syndrome after bariatric surgery. Results depending on the technique performed. Obes Surg. 2011;21(2):179–85.
Prachand VN, Ward M, Alverdy JC. Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > or = 50 kg/m2) compared with gastric bypass. J Gastrointest Surg. 2010;14(2):211–20.
Deitel M. Update: why diabetes does not resolve in some patients after bariatric surgery. Obes Surg. 2011;21(6):794–6.
Buse JB, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–5.
Stakkestad JA, Åsberg A. Brukerhåndbok i klinisk kjemi. Haugesund: Akademisk fagforlag AS; 2002.
Scopinaro N, et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care. 2005;28(10):2406–11.
Drapeau V, et al. Waist circumference is useless to assess the prevalence of metabolic abnormalities in severely obese women. Obes Surg. 2007;17(7):905–9.
Vage V, Gåsdal R, Laukeland C, et al. The biliopancreatic diversion with a duodenal switch (BPDDS): how is it optimally performed? Obes Surg. 2011;21(12):1864–9.
Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg. 2007;17(5):565–8.
Angervall L, Dotevall G, Tillander H. Amelioration of diabetes mellitus following gastric resection. Acta Med Scand. 1961;169:743–8.
Lee HC, et al. Early changes in incretin secretion after laparoscopic duodenal–jejunal bypass surgery in type 2 diabetic patients. Obes Surg. 2010;20(11):1530–5.
Patriti A, et al. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced proglucagon gene expression and L-cell number. Surgery. 2007;142(1):74–85.
Adami GF, et al. Recovery of insulin sensitivity in obese patients at short term after biliopancreatic diversion. J Surg Res. 2003;113(2):217–21.
Ahmed AR, et al. Laparoscopic Roux-en-Y gastric bypass and its early effect on blood pressure. Obes Surg. 2009;19(7):845–9.
Czupryniak L, et al. Circadian blood pressure variation in morbidly obese hypertensive patients undergoing gastric bypass surgery. Am J Hypertens. 2005;18(4 Pt 1):446–51.
Bueter M, et al. Bariatric surgery and hypertension. Surg Obes Relat Dis Off J Am Soc Bariatric Surg. 2009;5(5):615–20.
Sjostrom L, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.
Vage V, et al. Cardiovascular risk factors in obese patients treated with jejunoileal bypass operation: a 25-year follow-up study. Scand J Gastroenterol. 2005;40(1):90–5.
Naslund E, et al. Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg. 1998;8(3):253–60.
Scopinaro N, et al. A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations. Obes Surg. 2008;18(8):1035–8.
Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg. 2005;15(3):408–16.
Marceau P, et al. Duodenal switch: long-term results. Obes Surg. 2007;17(11):1421–30.
Iaconelli A, et al. Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care. 2011;34(3):561–7.
Casella G, Abbatini F, Cali B, et al. Ten-year duration of type 2 diabetes as prognostic factor for remission after sleeve gastrectomy. Surg Obes Relat Dis. 2011;7(6):697–702.
Sarkhosh K, Birch DW, Shi X et al. The impact of sleeve gastrectomy on hypertension: a systematic review. Obes Surg. 2012;22(5):832–7.
Conflict of Interest
The first author had travel expenses for one international conference in 2010 covered by Covidien Norway through an educational grant given to the Surgical Department, Unit for Bariatric Surgery, Førde Central Hospital. Roy M. Nilsen, Arnold Berstad, Jan Behme, Nils Sletteskog, Ronny Gåsdal, Camilla Laukeland, and Gunnar Mellgren do not have any commercial associations that might be a conflict of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Våge, V., Nilsen, R.M., Berstad, A. et al. Predictors for Remission of Major Components of the Metabolic Syndrome After Biliopancreatic Diversion with Duodenal Switch (BPDDS). OBES SURG 23, 80–86 (2013). https://doi.org/10.1007/s11695-012-0775-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-012-0775-0